Table-I.

Patient demographics (%, mean±SD).

Characteristics	Untreated CLL(n=30)	Remission CLL(n=20)	Control(n=20)
White blood cell count×109	63.89±83.67 (7.61-338.0)*	9.36±9.57(2.28-32.40) ▲	6.84±2.05(4.23-9.5)
Absolute lymphocyte count×109	52.18±82.91(5.12-321.01)*	6.89±8.52(0.87-24.99)* ▲	1.83±0.75(1.12-3.00)
Hemoglobin (g/L)	111.61±27.26(59-154)*	108.92±38.57(38-161)*	148.60±14.71(117-169)
Plateletes×109	107.14±67.73(23-262)*	118.25±57.99(35-244)*	180.00±52.17(102-286)
Rai clinical stage
0-II	10	7
III-IV	20	13
LDH(IU/L)	334.00±317.37(133-1258)*	240.45±96.31(115-412) ▲	181.89±23.82(124-213)
CD38 expression (cut-off 20%)
Positive	8	4
Negative	22	16

^* p<0.05 vs. Control,

^▲p<0.05 vs. Untreated CLL.